Up to half the cystic Fibrosis patients suffer from fungal infections in their lungs. This is caused by Aspergillus fumigatus, which is a spore-forming mould. According to the Cystic Fibrosis Foundation (CFF), many patients with cystic fibrosis, particularly young people, will develop an allergic reaction, Bronchopulmonary Aspergillosis, or BPA, to the fungus. You may experience severe symptoms such as wheezing, coughing, or other symptoms.

Oral drugs such as itraconazole are the current treatment. It is necessary to take high doses of the drug in order to reach the lungs. It can lead to liver toxicity and other serious side effects.

Itraconazole can be delivered directly to the lungs through inhalation. This is a more promising strategy. This is the strategy used by Pulmatrix, Inc., a Lexington, Mass-based pharmaceutical firm (NASDAQ: PULM). Pulmatrix was the first to create small, dense particles that are easy to inhale and combine them with drugs like itraconazole.

“We’ve urgently needed a way to deliver antifungal drugs directly to the lungs,”Expert at Stanford University in cystic Fibrosis Richard Moss M.D. “Pulmatrix’s PUR1900, using the inhaled dry particle technology, meets that need. It could offer major benefits to cystic fibrosis patients with fungal infections in their lungs.”

That’s why the U.S. Food & Drug Administration has granted the company’s request for orphan drug status for PUR1900, explaining that the designation “is based on a plausible hypothesis that [the] drug may be clinically superior to the same drug that is already approved.”

PUR1900 could improve the lives and quality of life for cystic-fibrosis patients, especially young children. However, Pulmatrix could also make significant revenues from it. Pulmatrix is an attractive investment opportunity because of the estimated cystic-fibrosis market, which could see tens to thousands of patients each year. The drug could also be used to treat millions of other pulmonary fungal infections, such as those that affect immunocompromised patients.

Go to for more information about PUR1900 ir.pulmatrix.comWatch the video below: https://www.youtube.com/watch?v=t8RgU8YUtjo.

Today’s life is very fast. People can check their kids’ soccer scores on the phone, while also sending emails to work with the help of digital technology. Consumers can expect the same conveniences and benefits from all businesses, except their insurance companies, thanks to the internet age. For many people struggling to pay their medical bills, this can seem like a long wait, even though 98 percent of claims for health insurance are processed in 30 days.

It’s not enough to simply be insured when nearly two-thirds American households make less than 2002. It is vital to understand how quickly and efficiently your insurance carrier pays claims. This is critical for both financial recovery and physical recovery.

Recent research found that 66% would not be able to adjust to the high financial cost of serious illnesses or injuries. Only 49% of workers have over $1,000 to pay out-of-pocket costs. Additionally, rising healthcare costs have forced employers to take cost-saving measures that are putting employees under greater financial pressure.

* Increasing employees’ health care insurance copayments.

* Increasing employees’ share of premium.

* Implementing high-deductible health plans with health savings accounts.

Some people might have to wait as long as a month to receive their insurance payments. Many insurance companies strive to provide fast service with better technology and better understanding of customers’ needs. This is one example. AflacIn the insurance industry, it is rare to find policies that allow for claims approval, processing, and payment within one day.

In the past, fast payment policies were a luxury. It’s a necessity. It’s vital to have funds readily available for serious illness or injury. You should ensure that your insurance company can move at your pace.

Aflac’s One Day Pay guarantee can be found on aflac.com/onedaypay.